EDIT (Editas) Rentabilitas dodolan miturut bathi reged

Lambang korporat lan logo Editas Medicine Inc (EDIT)

The lack of current pricing power is due to the early stage of CRISPR implementation. Editas Medicine, Inc. (EDIT) maintains internal business resilience through significant cash reserves and independence from consumer spending. Gross profit margins demonstrate the link between these factors and the genetic medicine market for patients, with the metric recorded at 95.80, which helps assess the company's operational efficiency.

EDIT - Margin reged Editas ing rentang 04.07.2022 - 20.11.2026

Rincian metrik keuangan lan pasar editasmedicine.com (EDIT)

- rincian posisi dhuwit lan arus kas:
Analisis dhasar perusahaan:Editas Medicine
Produk sing diprodhuksi Editas Medicine, Inc.

Gross margin measures the portion of revenue remaining after covering direct production costs, allowing for an assessment of internal profit generation efficiency. By analyzing the change in gross profit margin at the 95.80 level, an investor determines the ability of Editas Medicine, Inc. (EDIT) to monetize its CRISPR genome editing innovations for the therapy of hereditary blood and vision pathologies.

Pesaing langsung

Tingkat bathi miturut bathi reged Tempus AI Inc|QGEN (Qiagen NV) - Margin reged|Tingkat bathi miturut bathi reged Ionis Pharma (IONS)|Rentabilitas reged Repligen Corp (RGEN)|RNA - Margin bathi reged|crisprtx.com - Tingkat bathi miturut bathi reged|Tingkat bathi reged WGS|RARE - Rentabilitas reged|Beam Tx (BEAM) - Tingkat bathi miturut bathi reged|SRPT (Sarepta Therapeutics Inc) - Tingkat bathi miturut bathi reged|TWST: Rasio bathi reged|TXG (10xgenomics.com) - Margin reged|NTLA (Intellia Therapeutics, Inc.) - Rasio bathi reged|Rentabilitas reged Stoke Corp (STOK)|Rentabilitas dodolan miturut bathi reged BioLife|Margin reged WVE (Wave Life Sciences Ltd)|MAZE: Rentabilitas dodolan reged|Sionna Therapeutics, Inc. - Margin reged|Tingkat bathi reged PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Tingkat bathi miturut bathi reged|QURE - Rentabilitas dodolan miturut bathi reged|MGTX (MeiraGTx Corp) - Margin reged|Margin bathi reged REGENXBIO Inc. RGNX|Rentabilitas reged Solid Biosciences (SLDB)|Ocugen Corp - Rentabilitas dodolan reged|Rentabilitas reged Pacific Biosciences PACB|Rasio bathi reged BNTC (Benitec)|Design Corp - Margin reged|Rocket Pharmaceuticals - Rasio bathi reged|Rentabilitas dodolan reged 4D Molecular Therapeutics, Inc.|Margin bathi reged Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Margin reged|Rentabilitas reged SLN|Rentabilitas reged ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan reged|Rentabilitas reged Sangamo SGMO|NAUT: Rentabilitas dodolan reged|MGX: Tingkat bathi miturut bathi reged|Margin bathi reged Precision BioSciences|GBIO (generationbio.com) - Tingkat bathi miturut bathi reged|Margin bathi reged boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Margin reged|Rentabilitas dodolan reged IMNN (Imunon, Inc.)|Margin reged PHIO|MBIO - Margin bathi reged|Margin reged RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Margin bathi reged|Applied DNA - Margin reged|Margin bathi reged Bluebird Bio|ImmunoPrecise (IPA) - Rentabilitas reged|Tingkat bathi adhedhasar bathi reged OMGA (Omega)|Rentabilitas reged Singular Genomics Systems|Margin bathi reged regulusrx.com RGLS|Rentabilitas reged Syros Pharmaceuticals Inc. (SYRS)|Rentabilitas dodolan miturut bathi reged Codex DNA|Rentabilitas reged TRACON TCON|Unity Biotechnology, Inc - Rentabilitas reged